Portfolio - Indago Research

Be a Part of Medical Progress – Join the Vaccine Trial

Join in the fight against Covid/Flu Viruses
Are you eligible for our vaccine clinical research studies?
• No health insurance required
• Compensation for time and travel for qualified patients

Call Today!
786-772-0510

IMA Clinical Research is seeking healthy adults for our
groundbreaking vaccine research studies.
We are hoping to find new and effective options to fight
against the Covid and Influenza viruses.

Eligibility

• Ages 18 – 64
• In Generally Good Health

Benefits of Participation

• Potentially discover new and effective treatment options
• Compensation provided for time and travel (for qualified
patients)
• No health insurance required
Together we can make a real difference in medical advancements. Join us on our journey toward improved immunity!
To learn more about our studies and how to participate:
Call us

18-64 years old Healthy

Pursuing a more convenient vaccine for COVID-19 and flu

This study will help us learn if different investigational mRNA combination vaccines are safe and can help the body produce antibodies which may help fight off different strains of flu as well as COVID-19.

18 - 59 years old 18 years or older

Join a Clinical Trial Today That May Potentially Protect You From RSV Tomorrow

The purpose of this clinical trial is to assess the safety and immune response of an investigational vaccine aimed at preventing RSV infection in adults who have had an organ transplant or have preexisting health conditions. All participants in the RSVoice Trial will receive the investigational vaccine.

65 - 90 years old Osteoporosis

Are you over 60 years old and have been diagnosed with osteoporosis?

Doctors are testing an investigational drug to see if it is safe and works well to decrease the progression of osteoporosis. Volunteers who are postmenopausal and have been diagnosed with osteoporosis may be able to join.

50 years or older Healthy Vaccine

Potentially Protect Against Seasonal Flu and COVID-19 With a Single Injection

Learn more about participating in the Duo P301 Trial for an investigational combination vaccine aimed at preventing respiratory illness caused by both seasonal influenza (flu) and COVID-19 in adults 50 years of age and older

18 years or older

Do You Have Precirrhotic Nonalcoholic Steatohepatitis?

Doctors are testing an investigational drug to see if it is safe and works well to increase NASH resolution without worsening of fibrosis. Volunteers who have Precirrhotic non-alcoholic steatohepatitis may be able to join.

18 years or older

A clinical research study for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke

ACHIEVE-4 is a clinical research study for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke. The study will test how safe and well the investigational medicine (the medicine being studied) works for blood glucose and weight management compared with insulin therapy.

Can I join this study?

Yes, you may be able to join the research study if you:

Are aged 18 years or over
Have type 2 diabetes
Take at least 1 medicine to manage your diabetes
Have a BMI* of 25 or higher
Have or are at risk for heart disease, stroke, or other blood vessel diseases, or have kidney disease

*BMI stands for body mass index. If you do not know your BMI, please contact a healthcare professional.

40 years or older Cardiovascular Disease

Cardiovascular Disease Clinical Trial

Getting to the heart of cardiovascular disease

The VICTORION-2 PREVENT Study is testing an investigational drug to see whether it could help reduce the risk of future cardiovascular events, such as strokes and heart attacks, in people with cardiovascular disease (CVD).

If you are interested in taking part in the VICTORION-2 PREVENT Study, we’re searching for people who:

· Are 40 years of age and older

· Have previously experienced a heart attack, stroke or reduced blood flow to limbs caused by narrowed arteries (peripheral arterial disease)

· Are currently receiving a high-intensity statin (medication that lowers the level of harmful cholesterol in the blood)

There are other criteria that you will need to meet to qualify for participation in this study, which the study team can discuss with you.

For further information about the VICTORION-2 PREVENT Study, visit www.V2PSTUDY.com or contact:

786-772-0510

40 years or older Cardiovascular Disease

Join a clinical study looking to prevent heart attack or stroke in people at risk for heart disease

Researchers are conducting a new clinical research study designed to see if an investigational drug helps reduce the risk of future cardiovascular events, such as heart attacks and strokes.

12 years or older Covid vaccinated

COVID-19 Vaccine Clinical Trial

Staying up to date on your COVID-19 vaccines is still the best way to protect yourself and others from serious illness. However, as the virus continues to change, vaccines must evolve as well. For this reason, we are looking for ways to make our current COVID-19 vaccine more effective against the newest variants.

Older Posts